Western Investment Company Plans Special Shareholders Meeting
Upcoming Meeting for Shareholders
The Western Investment Company of Canada Limited (TSXV: WI) has announced an important event for its shareholders. This Annual General and Special Meeting will be held to discuss company operations and future directions. The meeting is set for December 6, 2024, and is a vital opportunity for registered shareholders and duly appointed proxyholders to engage directly with the company's management.
Details of the Meeting
Registered shareholders will have the chance to vote and submit questions at the meeting. It will convene at the offices of DS Lawyers Canada LLP, located in Dome Tower, Calgary. The exact address is Suite 800, Dome Tower, 333 – 7th Avenue S.W., Calgary, Alberta. The shareholder record date for determining eligibility to participate in the meeting is set for November 1, 2024. Attendees can expect an interactive session focused on the management's reports and proposed shareholder resolutions.
Stock Options Granted to Directors
In addition to the meeting, the Western Investment Company is recognizing its directors' contributions to the company. Subject to regulatory approval, options to purchase common shares have been granted to four directors. Each director will receive options for 30,000 common shares at an exercise price of $0.49 each, aligning with the most recent closing price on the TSX Venture Exchange. The options issued will vest immediately and will be available until October 16, 2034. This move demonstrates the company’s commitment to aligning directors' interests with those of the shareholders.
About the Company
Founded by a group of proactive Western Canadian businesspeople, the Western Investment Company is dedicated to investing in and supporting the growth of successful businesses in Western Canada. The company's vision is to foster ownership in the region's local enterprises. As a publicly traded entity, Western's shares are actively traded on the TSX Venture Exchange under the symbol WI.
For more information about the Western Investment Company, shareholders and potential investors are encouraged to visit the company’s website, where they can find current updates and resources.
Contact Information
To learn more or ask questions regarding the upcoming meeting, interested parties can reach out to Scott Tannas, the President and CEO of the Western Investment Company. He can be contacted at (403) 652-0408 and is available to discuss any inquiries shareholders may have.
Frequently Asked Questions
What is the purpose of the upcoming meeting?
The meeting provides shareholders with the opportunity to engage with company management, vote on resolutions, and ask questions regarding the company’s direction.
Where will the meeting take place?
The meeting will be held at the offices of DS Lawyers Canada LLP, located in Calgary, Alberta.
What are the stock option details for directors?
Directors have been granted options to purchase 30,000 common shares at $0.49 each, which vest immediately and expire in 2034.
How can shareholders participate in the meeting?
Registered shareholders and appointed proxyholders can participate, vote, and submit questions during the meeting.
Who can I contact for further information?
Scott Tannas, President and CEO, can be contacted at (403) 652-0408 for any inquiries related to the meeting or the company.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Toyota Ignites Excitement with Gazoo Racing Expansion Plans
- T-Mobile Plans Major Redemption of Sprint Notes Next Year
- Oshkosh Corporation Plans Earnings Announcement for Q3 2024
- Roku Plans to Release Q3 2024 Financial Results This Fall
- Brightcove Plans Earnings Report and Live Stream Event Soon
- Golden Entertainment Plans Earnings Release and Conference Call
- Manitowoc Company Prepares for Q3 2024 Earnings Call
- Schneider National Plans to Reveal Q3 2024 Earnings Soon
- Calumet Specialty Products Partners Gains Momentum with DoE Support
- Evergy Plans Earnings Call to Unveil Q3 2024 Insights
Recent Articles
- Antelope Enterprise's Bold Steps into the Lucrative US Energy Sector
- Anavex Life Sciences Unveils Phase 2 Results for ANAVEX®3-71
- SemiCab Teams Up with Apollo Tyres for Scalable Logistics
- Ocugen Gears Up for Upcoming Conference Call: Insights Ahead
- Brunswick Exploration Unveils Promising Lithium Findings in Canada
- Psyence Biomed Advances Development of Psilocybin-Based Therapies
- Firan Technology Group Corporation Joins OTCQX for Growth
- Agios Pharmaceuticals Set to Showcase Q3 2024 Results
- GXO Expands Partnership with Henkel to Include Beauty Services
- Amicus Therapeutics Reaches Settlement on Galafold Patent Dispute
- Avacta Unveils Two Innovative Oncology Assets for Growth
- Harvia Plc Announces Second Dividend Installment of EUR 0.34
- CIB Marine Bancshares Finalizes Redemption of Preferred Stock
- Chicago Atlantic Real Estate Finance Reveals Q3 Earnings Schedule
- Travere Therapeutics’ FILSPARI Gains Swiss Regulatory Approval
- KFSHRC's Innovative Healthcare Solutions at Global Exhibition
- Man Group PLC Provides Insight on Keywords Studios Plc Holdings
- Ontario Coalition Takes Stand Against Orchard Villa Expansion
- Discover Draganfly's Cutting-Edge Drone Solutions at Wings Event
- Appili Therapeutics Advances Potential Tularemia Vaccine ATI-1701
- ECARX Announces Upcoming Earnings Call for Q3 Financials
- Bombardier Leads the Way at NBAA-BACE 2024 Celebrations
- Agios Pharmaceuticals to Host Q3 2024 Results Webcast
- CytoSorbents Corporation Prepares for Q3 Results Announcement
- Rapid Diagnostic Kits Market Growth Projected at $26 Billion by 2034
- Amicus Therapeutics and Teva Settle GALAFOLD Patent Disputes
- DATA Communications Management's Commitment to Sustainability
- Guardian Capital Unveils Cash Distribution Plans for ETFs
- Psyence Biomed Advances Its PsyLabs Partnership Progress
- Tilray Brands Marks Six Years of Canadian Cannabis Pioneer Success
- Huntington Bancshares Reports Strong Q3 2024 Earnings Results
- USU Honored as a Technology Leader in IT Service Management
- Monument Real Estate Services Partners with Funnel for Efficiency
- ASMO Expands in Saudi Arabia with Strategic Partnerships
- Vietjet Thailand Shines Bright at Global Brand Awards 2024
- Trump Edges Out Harris in Close Presidential Race Poll
- Averna Expands Collaboration with Kyrio for Enhanced DOCSIS
- enCore Energy Corp. Welcomes New Board Member for Growth
- Brian Hovey Takes the Helm as CMO of Rockwell Automation
- CSX Stock Faces Challenges Amid Severe Weather Outlook
- Sage Therapeutics Implements Restructuring Amid Financial Challenges
- Marinus Pharmaceuticals Achieves Breakthrough in Epilepsy Treatment
- U.S. Bancorp Sees Stock Surge as Earnings and Growth Shine
- BofA Upgrades O-I Glass: A Strategic Move for Investors
- JPMorgan Optimistic About Kyverna Therapeutics' Growth in CAR-T Space
- Oppenheimer Updates Price Target for ServiceNow’s Stock
- RBC Capital Markets Upgrades First Horizon Price Target to $20
- Wells Fargo's Insights on Q3 Earnings and Market Expectations
- Travelers (NYSE: TRV) Surpasses Earnings Forecast Significantly
- Russell 2000 Hits New Heights as Market's Confidence Grows